Oman Pharmaceuticals & Healthcare Q2 2018
Oman's growing chronic disease burden will drive demand for healthcare and underpin growth of the pharmaceuticalmarket. However manufacturers will face headwinds from cost containment measures in the public provision of pharmaceuticalsand healthcare services. Phased pharmaceutical price reductions pose near-term risks for manufacturers and importers.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook